Mesenchymal Stem Cells Induce Expression of CD73 in Human Monocytes In Vitro and in a Swine Model of Myocardial Infarction In Vivo

Authors:
Open Access
Publisher website
Google Scholar
Abstract
The ectoenzymes CD39 and CD73 regulate the purinergic signaling through the hydrolysis of adenosine triphosphate (ATP)/ADP to AMP and to adenosine (Ado), respectively. This shifts the pro-inflammatory milieu induced by extracellular ATP to the anti-inflammatory regulation by Ado. Mesenchymal stem cells (MSCs) have potent immunomodulatory capabilities, including monocyte modulation toward an anti-inflammatory phenotype aiding tissue repair. In vitro, we observed that human cardiac adipose tissue-derived MSCs (cATMSCs) and umbilical cord MSCs similarly polarize monocytes toward a regulatory M2 phenotype, which maintained the expression of CD39 and induced expression of CD73 in a cell contact dependent fashion, correlating with increased functional activity. In addition, the local treatment with porcine cATMSCs using an engineered bioactive graft promoted the in vivo CD73 expression on host monocytes in a swine model of myocardial infarction. Our results suggest the upregulation of ectonucleotidases on MSC-conditioned monocytes as an effective mechanism to amplify the long-lasting immunomodulatory and healing effects of MSCs delivery.
Funding Information
  • Instituto de Salud Carlos III (PI14/01682, REDINREN RD16/0009 Feder Funds, TerCel RD16/00111/0006, CB16/11/00403)
  • Departament d’Innovació, Universitats i Empresa, Generalitat de Catalunya (2014SGR804, 2014SGR699, 2014FI B00649, 2014BP B00118)
  • Ministerio de Economía y Competitividad (SAF2014-59892-R)
  • Fundació la Marató de TV3 (201502, 201516)

This publication has 67 references indexed in Scilit: